STOCK TITAN

Mineralys Therapeutics to Participate in the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Mineralys Therapeutics, Inc. will be giving a presentation at the Jefferies Healthcare Conference on June 9, 2023. The live webcast can be accessed on the company's website.
Positive
  • Mineralys Therapeutics will be presenting at the Jefferies Healthcare Conference, which could generate positive investor interest.
  • Investors can access the live webcast of the presentation on the Mineralys website, providing an opportunity to gain valuable insights into the company's developments.
Negative
  • No negative takes found.

RADNOR, Pa., May 31, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, today announced that its Chief Executive Officer Jon Congleton, and Chief Financial Officer and Chief Business Officer, Adam Levy, will be giving a presentation at the Jefferies Healthcare Conference in New York at 9:30 a.m. ET on Friday, June 9, 2023.

The live webcast of the presentation can be accessed under “News and Events” on the Investor Relations section of the Mineralys website at www.mineralystx.com. A replay of the webcast will be available on the Company’s website for approximately 90 days.

2023 Jefferies Healthcare Conference:

Date: Friday, June 9, 2023
Time:9:30 a.m. ET
Webcast Link 

About Mineralys

Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that Mineralys Therapeutics is initially developing for the treatment of patients with uncontrolled or resistant hypertension. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn and Twitter.

Contact:

Investor Relations
investorrelations@mineralystx.com

Media Relations
Tom Weible
Elixir Health Public Relations
Phone: (1) 515-707-9678
Email: tweible@elixirhealthpr.com


FAQ

When and where is the Jefferies Healthcare Conference?

The Jefferies Healthcare Conference is on June 9, 2023, in New York.

Where can investors access the live webcast of the presentation?

Investors can access the live webcast on the Mineralys website under the 'News and Events' section.

How long will the webcast be available for replay?

The webcast will be available for approximately 90 days on the company's website.

Mineralys Therapeutics, Inc.

NASDAQ:MLYS

MLYS Rankings

MLYS Latest News

MLYS Stock Data

666.34M
49.73M
2.55%
100.62%
3.24%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
RADNOR